Polymer compositions with bioactive agent, medical articles, and methods

• US 7,745,509 B2
• Filed: 12/05/2003
• Issued: 06/29/2010
• Est. Priority Date: 12/05/2003
• Status: Active Grant

• Current Assignee: 3M Innovative Properties Company (3M Company)
• Original Assignee: 3M Innovative Properties Company (3M Company)
• Inventors: Rao, Prabhakara S., Ylitalo, Caroline M., Burton, Scott A., Hyde, Patrick D.
• Primary Examiner(s): NERANGIS, VICKEY MARIE
• Application Number:
  US10/728,439
• Publication Number:
  US 20050124724A1
• Time in Patent Office: 2,398 Days
• Field of Search: 523/122, 523/205, 524/430, 524/431, 524/916, 524/432, 424/617
• US Class Current: 523/122
• CPC Class Codes: A61L 15/18 containing inorganic materials
• CPC Class Codes: A61L 15/22 containing macromolecular materials
• CPC Class Codes: A61L 15/46 Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
• CPC Class Codes: A61L 2300/102 Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
• CPC Class Codes: A61L 2300/104 Silver, e.g. silver sulfadiazine
• CPC Class Codes: A61L 2300/622 Microcapsules
• CPC Class Codes: A61P 17/02 for treating wounds, ulcers, burns, scars, keloids, or the like
• CPC Class Codes: A61P 31/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Abstract

A polymer composition that includes a hydrophilic polymer, an optional secondary organic polymer, and a bioactive agent distributed therein, wherein the bioactive agent is selected from the group consisting of a silver compound, a copper compound, a zinc compound, and combinations thereof.

Claims

1. A polymer composition comprising:

a continuous hydrophobic phase comprising a mixture comprising;

a hydrophobic liquid comprising mineral oil; and

a hydrophobic thermoplastic elastomeric polymer;

absorbent hydrophilic microparticles dispersed within the hydrophobic liquid, wherein the hydrophilic microparticles comprise a crosslinked carboxylic acid-containing organic polymer; and

a bioactive agent having a particle size less than one micron dispersed in the hydrophilic microparticles, wherein the bioactive agent is selected from the group consisting of a metal oxide of silver, a metal oxide of copper, a metal oxide of zinc, and combinations thereof;

wherein the polymer composition is nonadherent and contains less than 1 wt % water based on the total weight of the composition.

2. The polymer composition of claim 1 wherein the absorbent hydrophilic microparticles have an average particle size of 10 microns or less, when in a nonhydrated form.

3. The polymer composition of claim 2 wherein the absorbent hydrophilic microparticles have an average particle size of 1 micron or less, when in a nonhydrated form.

4. The polymer composition of claim 3 wherein the absorbent hydrophilic microparticles have an average particle size of 0.5 micron to 1 micron when in a nonhydrated form.

5. The polymer composition of claim 2 further comprising secondary absorbent particles having an average particle size of greater than 10 microns when in a nonhydrated form.

6. The polymer composition of claim 5 wherein the secondary absorbent particles having an average particle size of greater than 10 microns are superabsorbent.

7. The polymer composition of claim 1 wherein the microparticles are superabsorbent.

8. The polymer composition of claim 1 wherein the carboxylic acid-containing organic polymer comprises a copolymer of sodium acrylate and acrylic acid.

9. The polymer composition of claim 1 wherein the thermoplastic elastomeric polymer is selected from the group consisting of a styrene-isoprene block copolymer, a styrene-(ethylene/butylene) block copolymer, a styrene-(ethylene/propylene) block copolymer, a styrene-isoprene-styrene block copolymer, a styrene-butadiene block copolymer, a polyetherester, a poly-alpha-olefin based thermoplastic elastomeric polymer, an ethylene-1-octene copolymer, and combinations thereof.

10. The polymer composition of claim 9 wherein the thermoplastic elastomeric polymer is selected from the group consisting of styrene-isoprene-styrene (SIS), styrene-butadiene-styrene (SBS), styrene-ethylene-propylene-styrene (SEPS), styrene-ethylene-butylene-styrene (SEBS), and combinations thereof.

11. The polymer composition of claim 1 further comprising an additive selected from the group consisting of a plasticizer, a crosslinking agent, a stabilizer, an extruding aid, a filler, a pigment, a dye, a swelling agent, a foaming agent, a chain transfer agent, and combinations thereof.

12. The polymer composition of claim 1 wherein the microparticles are present in an amount of 1 wt-% to 60 wt-%, based on the total weight of the polymer composition.

13. The polymer composition of claim 1 wherein the composition is stable.

14. The polymer composition of claim 1 wherein the composition is in the form of a hydrocolloid.

15. The polymer composition of claim 1 further comprising a swelling agent.

16. The polymer composition of claim 1 wherein the bioactive agent is silver oxide.

17. A medical article comprising the polymer composition of claim 1.

18. A polymer composition comprising:

a continuous hydrophobic phase comprising a mixture comprising;

mineral oil; and

a hydrophobic thermoplastic elastomeric polymer selected from the group consisting of styrene-isoprene-styrene (SIS), styrene-butadiene-styrene (SBS), styrene-ethylene-propylene-styrene (SEPS), styrene-ethylene-butylene-styrene (SEBS), and combinations thereof;

absorbent hydrophilic microparticles dispersed within the mineral oil, wherein the hydrophilic microparticles comprise a crosslinked carboxylic acid-containing organic polymer; and

a bioactive agent having a particle size less than one micron dispersed in the hydrophilic microparticles, wherein the bioactive agent is selected from the group consisting of a metal oxide of silver, a metal oxide of copper, a metal oxide of zinc, and combinations thereof;

wherein the polymer composition is nonadherent and contains less than 1 wt % water based on the total weight of the composition.

19. The polymer composition of claim 18 wherein the bioactive agent is silver oxide.

20. The polymer composition of claim 18 wherein the carboxylic acid-containing organic polymer comprises a copolymer of sodium acrylate and acrylic acid.

21. A medical article comprising the polymer composition of claim 18.

22. A polymer composition comprising:

a continuous hydrophobic phase comprising a mixture comprising;

mineral oil; and

a hydrophobic thermoplastic elastomeric polymer selected from the group consisting of styrene-isoprene-styrene (SIS), styrene-butadiene-styrene (SBS), styrene-ethylene-propylene-styrene (SEPS), styrene-ethylene-butylene-styrene (SEBS), and combinations thereof;

absorbent hydrophilic microparticles dispersed within the mineral oil, wherein the hydrophilic microparticles comprise a crosslinked a copolymer of sodium acrylate and acrylic acid; and

silver oxide having a particle size less than one micron dispersed in the hydrophilic microparticles;

wherein the polymer composition is nonadherent and contains less than 1 wt % water based on the total weight of the composition.

23. A medical article comprising the polymer composition of claim 22.